Qualigen Therapeutics Inc

NASDAQ:QLGN   3:53:48 PM EDT
1.78
+0.08 (+4.71%)
Earnings Announcements

Qualigen Therapeutics Reports Q3 Loss Per Share $0.10

Published: 11/15/2021 14:23 GMT
Qualigen Therapeutics Inc (QLGN) - Qualigen Therapeutics, Inc. Reports Third Quarter 2021 Financial Results.
Q3 Revenue $1.2 Million.
Q3 Loss per Share $0.10.
Believes Its Cash and Cash Equivalents Are Sufficient to Fund Its Anticipated Operations Through Late 2022.
Revenue is expected to be $1.32 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $1 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.